Treatment of Subarachnoid Hemorrhage With Human Albumin


Phase N/A Results

Summary of Purpose

The purpose of this study is to evaluate the tolerability and safety of 25 percent human albumin therapy in patients with subarachnoid hemorrhage. Trial Stopped: Study met safety endpoints

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 March 2015.

1 Jan 2006 26 Jan 2006 1 Jan 2011 1 Apr 2011 1 Mar 2015 5 Feb 2013
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Intervention: Parallel Assignment


  • Jose I. Suarez, MD